A cancer registry is an information system designed to collect, manage and analyze data on individuals diagnosed with the malignant or neoplastic disease (cancer). Free software applications are publicly available for collecting and analyzing cancer patients’ related data.
New York, March 20, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Cancer Registry Software Market By Type By Deployment Type By Component By End User By Region, Industry Analysis and Forecast, 2019 - 2025" - https://www.reportlinker.com/p05876891/?utm_source=GNW
Cancer registry software offers in-depth information on state and global cancer statistics. To maintain records providing high-quality data, the National Program of Cancer Registries (NPCR) of the Centers for Disease Control and Prevention (CDC) offers support to nations and states. There are appointed registrars who need to manage and keep the registry updated.
Most of these cancer registrars are employed in hospitals. Other work settings and centers for registrars usually involve standard-setting organizations, government agencies, central or state cancer registries, pharmaceutical companies, staffing firms, software vendors, and insurance agencies. Moreover, various self-employed cancer registrars also exist in the industry. The National Cancer Registrars Association (NCRA), a non-profit association, includes registry professionals and Certified Tumor Registrars (CTR).
The cancer registry program helps to simplify data collection for national and state registries, further helping to monitor the effectiveness of different treatment strategies. In addition, the data collected by the state registries help to better identify and treat the disease. The data collected are important to attack risk factors, like sun exposure, tobacco use, or certain environmental factors, including chemical and radiation exposure. Such information is also needed for places to be identified where screening and treatment services should be tracked and enhanced. In addition, registry data are useful for research institutes to estimate the efficacy of the cancer control, treatment, and prevention program.
Based on Type, the market is segmented into Integrated and Standalone. Based on Deployment Type, the market is segmented into On-premise and Cloud-based. Based on Component, the market is segmented into Commercial and Public. Based on End User, the market is segmented into Government & Third party, Research Centers, Hospital & Medical Centers, Private Payers and Pharma Biotech & Medical Device Suppliers. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, McKesson Corporation, Conduent, Incorporated, Elekta AB, Ordinal Data, Inc., Onco, Inc., C/Net Solutions, Rocky Mountain Cancer Data System, Electronic Registry System, Inc., and Himagine Solutions, Inc.
Scope of the Study
By Deployment Type
By End User
• Government & Third party
• Research Centers
• Hospital & Medical Centers
• Private Payers
• Pharma Biotech & Medical Device Suppliers
• North America
o Rest of North America
o Rest of Europe
• Asia Pacific
o South Korea
o Rest of Asia Pacific
o Saudi Arabia
o South Africa
o Rest of LAMEA
• IBM Corporation
• McKesson Corporation
• Conduent, Incorporated
• Elekta AB
• Ordinal Data, Inc.
• Onco, Inc.
• C/Net Solutions
• Rocky Mountain Cancer Data System
• Electronic Registry System, Inc.
• Himagine Solutions, Inc.
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Read the full report: https://www.reportlinker.com/p05876891/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Intl: +1 339-368-6001